Equities

Progenics Pharmaceuticals Inc

Progenics Pharmaceuticals Inc

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (USD)6.01
  • Today's Change-0.11 / -1.80%
  • Shares traded853.32k
  • 1 Year change-15.23%
  • Beta2.4748
Data delayed at least 15 minutes, as of Sep 23 2016 21:00 BST.
More ▼

Events & Activity

  • PGNX:NSQ price moved over +1.14% to 6.23
  • PGNX:NSQ price falls below 50-day moving average to 6.17 at 10:59 BST
  • PGNX:NSQ price falls below 50-day moving average to 6.16 at 10:39 BST
  • PGNX:NSQ price rises above 15-day moving average to 6.19 at 10:31 BST
  • PGNX:NSQ price falls below 15-day moving average to 6.17 at 10:59 BST
  • PGNX:NSQ price rises above 15-day moving average to 6.19 at 10:30 BST
  • PGNX:NSQ price rises above 15-day moving average to 6.23 at 10:31 BST

Key statistics

On Friday, Progenics Pharmaceuticals Inc (PGNX:NSQ) closed at 6.01, -28.20% below its 52-week high of 8.37, set on Nov 03, 2015.
52-week range
Today
3.61Feb 09 20168.37Nov 03 2015
Markit short selling activity
Low
Med
High
Open6.12
High6.19
Low6.00
Bid5.22
Offer6.10
Previous close6.12
Average volume898.88k
Shares outstanding69.99m
Free float68.82m
P/E (TTM)--
Market cap420.61m USD
EPS (TTM)-0.5075 USD
Data delayed at least 15 minutes, as of Sep 23 2016 21:00 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.